NeuroTherapia, Inc.
PrivateLast Round
Series B
Aug 6, 2024
Total Funding Raised
$11.5M
Company Overview
NeuroTherapia, Inc. is a clinical-stage biotechnology company developing oral, small-molecule drugs to address neuro-inflammatory conditions of the central nervous system, including Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroTherapia, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroTherapia, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 6, 2024 | ||||
| Series A | Sep 22, 2020 | ||||
| Grant | Sep 21, 2016 | ||||
| Seed | Oct 13, 2015 |
Key People
Founding team and executive leadership
NeuroTherapia, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brain Trust Accelerator Fund | Series B, Series A |
| Dolby Family Ventures | Series B, Series A |
| The Foundation For A Better World | Series B |
| Alzheimer's Drug Discovery Foundation | Series B, Series A, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 6, 2024
$12M round led by Cleveland Clinic
- Sep 22, 2020
$9M round led by Brain Trust Accelerator Fund II.
NeuroTherapia, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroTherapia, Inc.'s valuation, stock price, and market status.